Prevalence of Patients Receiving Urate-Lowering Medicine in Greenland and Denmark: A Cross-Sectional Case–Control Study
This study estimates the age- and sex-specific prevalence of patients receiving urate-lowering therapy (ULT) in Greenland and compares the results with estimates in Denmark. Characteristics of patients receiving ULT in Greenland were compared to age- and sex-matched controls. The study was designed...
Published in: | International Journal of Environmental Research and Public Health |
---|---|
Main Authors: | , , , , , |
Format: | Text |
Language: | English |
Published: |
MDPI
2022
|
Subjects: | |
Online Access: | http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9223075/ https://doi.org/10.3390/ijerph19127247 |
id |
ftpubmed:oai:pubmedcentral.nih.gov:9223075 |
---|---|
record_format |
openpolar |
spelling |
ftpubmed:oai:pubmedcentral.nih.gov:9223075 2023-05-15T16:23:22+02:00 Prevalence of Patients Receiving Urate-Lowering Medicine in Greenland and Denmark: A Cross-Sectional Case–Control Study Hull, Sidsel Dan Andersen, Marianne Welzel Bengtsson, Jessica Skovgaard, Nils Backe, Marie Balslev Pedersen, Michael Lynge 2022-06-13 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9223075/ https://doi.org/10.3390/ijerph19127247 en eng MDPI http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9223075/ http://dx.doi.org/10.3390/ijerph19127247 © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). CC-BY Int J Environ Res Public Health Article Text 2022 ftpubmed https://doi.org/10.3390/ijerph19127247 2022-06-26T01:03:04Z This study estimates the age- and sex-specific prevalence of patients receiving urate-lowering therapy (ULT) in Greenland and compares the results with estimates in Denmark. Characteristics of patients receiving ULT in Greenland were compared to age- and sex-matched controls. The study was designed as a cross-sectional case–control study based on nationwide data from medical and population registers in Greenland and Denmark. The prevalence of patients receiving ULT was significantly lower in Greenland (0.55%) compared to Denmark (1.40%) (p < 0.001). In both countries, the prevalence increased with age and was higher among men compared to women. In Greenland, patients receiving ULT were more often overweight, and more frequently received blood glucose-, lipid-, and blood pressure-lowering medicine including diuretics compared to age- and sex-matched controls. The prevalence of patients receiving ULT was significantly lower in Greenland compared to Denmark. Common life-style related risk factors for hyperuricemia and gout were observed frequently among ULT-treated patients compared to controls. Along with an increasing prevalence of lifestyle-related diseases in Greenland, the prevalence of patients receiving ULT may increase in the years to come. More focus on detection and management of hyperuricemia and gout in Greenland is warranted to improve quality of health care. Text Greenland PubMed Central (PMC) Greenland International Journal of Environmental Research and Public Health 19 12 7247 |
institution |
Open Polar |
collection |
PubMed Central (PMC) |
op_collection_id |
ftpubmed |
language |
English |
topic |
Article |
spellingShingle |
Article Hull, Sidsel Dan Andersen, Marianne Welzel Bengtsson, Jessica Skovgaard, Nils Backe, Marie Balslev Pedersen, Michael Lynge Prevalence of Patients Receiving Urate-Lowering Medicine in Greenland and Denmark: A Cross-Sectional Case–Control Study |
topic_facet |
Article |
description |
This study estimates the age- and sex-specific prevalence of patients receiving urate-lowering therapy (ULT) in Greenland and compares the results with estimates in Denmark. Characteristics of patients receiving ULT in Greenland were compared to age- and sex-matched controls. The study was designed as a cross-sectional case–control study based on nationwide data from medical and population registers in Greenland and Denmark. The prevalence of patients receiving ULT was significantly lower in Greenland (0.55%) compared to Denmark (1.40%) (p < 0.001). In both countries, the prevalence increased with age and was higher among men compared to women. In Greenland, patients receiving ULT were more often overweight, and more frequently received blood glucose-, lipid-, and blood pressure-lowering medicine including diuretics compared to age- and sex-matched controls. The prevalence of patients receiving ULT was significantly lower in Greenland compared to Denmark. Common life-style related risk factors for hyperuricemia and gout were observed frequently among ULT-treated patients compared to controls. Along with an increasing prevalence of lifestyle-related diseases in Greenland, the prevalence of patients receiving ULT may increase in the years to come. More focus on detection and management of hyperuricemia and gout in Greenland is warranted to improve quality of health care. |
format |
Text |
author |
Hull, Sidsel Dan Andersen, Marianne Welzel Bengtsson, Jessica Skovgaard, Nils Backe, Marie Balslev Pedersen, Michael Lynge |
author_facet |
Hull, Sidsel Dan Andersen, Marianne Welzel Bengtsson, Jessica Skovgaard, Nils Backe, Marie Balslev Pedersen, Michael Lynge |
author_sort |
Hull, Sidsel Dan |
title |
Prevalence of Patients Receiving Urate-Lowering Medicine in Greenland and Denmark: A Cross-Sectional Case–Control Study |
title_short |
Prevalence of Patients Receiving Urate-Lowering Medicine in Greenland and Denmark: A Cross-Sectional Case–Control Study |
title_full |
Prevalence of Patients Receiving Urate-Lowering Medicine in Greenland and Denmark: A Cross-Sectional Case–Control Study |
title_fullStr |
Prevalence of Patients Receiving Urate-Lowering Medicine in Greenland and Denmark: A Cross-Sectional Case–Control Study |
title_full_unstemmed |
Prevalence of Patients Receiving Urate-Lowering Medicine in Greenland and Denmark: A Cross-Sectional Case–Control Study |
title_sort |
prevalence of patients receiving urate-lowering medicine in greenland and denmark: a cross-sectional case–control study |
publisher |
MDPI |
publishDate |
2022 |
url |
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9223075/ https://doi.org/10.3390/ijerph19127247 |
geographic |
Greenland |
geographic_facet |
Greenland |
genre |
Greenland |
genre_facet |
Greenland |
op_source |
Int J Environ Res Public Health |
op_relation |
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9223075/ http://dx.doi.org/10.3390/ijerph19127247 |
op_rights |
© 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
op_rightsnorm |
CC-BY |
op_doi |
https://doi.org/10.3390/ijerph19127247 |
container_title |
International Journal of Environmental Research and Public Health |
container_volume |
19 |
container_issue |
12 |
container_start_page |
7247 |
_version_ |
1766011614498127872 |